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SUMMARY  34 
Ail, a multifunctional outer membrane protein of Yersinia pestis, confers cell binding, 35 
Yop delivery, and serum resistance activities. Resistance to complement proteins in serum is 36 
critical for survival of Y. pestis during the septicemic stage of plague infections. Bacteria employ 37 
a variety of tactics to evade the complement system, including recruitment of complement 38 
regulatory factors, such as factor H, C4b-binding protein (C4BP), and vitronectin (Vn). Y. pestis 39 
Ail interacts with the regulatory factors Vn and C4BP, and Ail homologs from Y. enterocolitica 40 
and Y. pseudotuberculosis recruit factor H. Using co-sedimentation assays, we demonstrate that 41 
two surface-exposed amino acids, F80 and F130, are required for interaction of Y. pestis Ail with 42 
Vn, factor H, and C4BP. However, although Ail-F80A/F130A fails to interact with these 43 
complement regulatory proteins, it still confers 10,000-fold more serum resistance than a Δail 44 
strain and prevents C9 polymerization, potentially by directly interfering with MAC assembly.  45 
Using site-directed mutagenesis we further defined this additional mechanism of complement 46 
evasion conferred by Ail. Finally, we find that at Y. pestis concentrations reflective of early-stage 47 
septicemic plague, Ail weakly recruits Vn and fails to recruit factor H, suggesting that this 48 
alternative mechanism of serum resistance may be essential during plague infection.  49 
INTRODUCTION 50 
Yersinia pestis¸ a gram-negative rod, is the causative agent of plague, a rapidly progressing, 51 
often fatal disease (Perry & Fetherston, 1997). The bacterium is primarily transmitted to 52 
humans through the bite of infected fleas (Perry & Fetherston, 1997, Sebbane et al., 2005, 53 
Hinnebusch et al., 1996, Hinnebusch, 2005), where it enters the tissue and travels to the 54 
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nearest regional lymph node (bubonic plague) (Perry & Fetherston, 1997). After growing to high 55 
numbers in the regional lymph node, Y. pestis can enter the bloodstream (septicemic plague), 56 
and spread to other blood-filtering organs including the liver and spleen. Once in the blood, Y. 57 
pestis can also spread to the lungs progressing to secondary pneumonic plague. At this point 58 
the infection can be spread human to human via respiratory droplets resulting in primary 59 
pneumonic plague, a rapidly fatal disease (Perry & Fetherston, 1997).  60 
 For host-host transmission via fleas, progression of a plague infection from buboes to 61 
the blood, and human to human transmission via respiratory droplets, it is critical that Y. pestis 62 
survive in human blood. Human complement, an innate immune defense mechanism against 63 
bacterial infections, is present in blood. Thus, Y. pestis must be able to evade complement to 64 
grow and survive in the host. The human complement system consists of three pathways: the 65 
classical pathway (CP), the lectin pathway (LP), and the alternative pathway (AP). CP and LP, 66 
upon activation by antibodies or ficolins/mannose-binding lectins respectively, both lead to C4 67 
cleavage to C4b. After forming an ester linkage with a cellular target, C4b can initiate formation 68 
of the CP/LP C3 convertase (C4b2a). The CP/LP C3 convertase cleaves C3 into C3a, an 69 
anaphylatoxin that induces a proinflammatory response (Klos et al., 2009), and C3b. C3b can 70 
either act as an opsonin for complement receptors on phagocytes or become incorporated into 71 
the CP/LP C5-convertase (C4b2a3b). C5 convertase is a serine protease that cleaves C5 into C5a 72 
and C5b. C5a is an additional anaphylatoxin and C5b can initiate assembly of the membrane 73 
attack complex (MAC) by interacting with C6 (Merle et al., 2015). C5bC6 then interacts with C7. 74 
Upon interaction with C8, the complex becomes membrane embedded and then finally C9 is 75 
recruited (Merle et al., 2015). Interaction of C5b-8 with C9 initiates polymerization of 12-18 C9 76 
monomers into a ring structure called the membrane attack complex (MAC) (Tschopp et al., 77 
1984, Serna et al., 2016). Assembly of the MAC in membranes of gram-negative bacteria leads 78 
to disruption of the bacterial membrane and osmotic lysis (Merle et al., 2015, Tegla et al., 2011, 79 
Serna et al., 2016).  80 
The alternative pathway (AP) of complement differs from the CP/LP in the steps of 81 
initiation. The AP begins with spontaneous hydrolysis of C3 in the blood plasma (Pangburn & 82 
Müller-Eberhard, 1983). This leads to the formation of a covalent ester bond between C3b and 83 
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cellular target molecules, followed by interaction of C3b with Factor B (Law et al., 1979, Müller-84 
Eberhard & Götze, 1972). A conformational change in Factor B after binding C3b allows for 85 
cleavage by Factor D, resulting in two fragments, Ba and Bb, and creating the active AP C3-86 
convertase, C3bBb (Lesavre et al., 1979). Positive feedback and cleavage of more C3 into C3a 87 
and C3b by the AP C3-convertase leads to formation of the AP C5 convertase, (C3bBbC3b). 88 
From there, the AP follows the same pathway for MAC formation as CP/LP (Pangburn & 89 
Müller-Eberhard, 1983). 90 
Regulatory factors of the complement system exist to prevent uncontrolled or 91 
inadvertent progression of the cascade on host cells. The fluid-phase regulator of the CP/LP, 92 
C4b-binding protein (C4BP), exists in the blood plasma and regulates activation of the cascade 93 
by acting as a cofactor for factor I-mediated inactivation of C4b, accelerating the decay of the 94 
CP/LP C3 convertase, and preventing assembly of the convertase by competitively binding C4b, 95 
thus preventing binding of C2 (Blom et al., 2004). Analogous to C4BP, factor H regulates the 96 
alternative pathway by binding surface molecules (often on host cells) and facilitating factor I-97 
mediated cleavage and inactivation of C3b, as well as accelerating decay and preventing 98 
assembly of the AP C3 convertase before it can become an active component of the C3 99 
convertase and drive assembly of the MAC (Pangburn & Müller-Eberhard, 1983, Whaley & 100 
Ruddy, 1976, Weiler et al., 1976). An additional regulator of complement activation is 101 
vitronectin. Vitronectin can inhibit formation of the MAC by binding the C5b-C7 complex (and 102 
C5b-C8 and C5b-C9 complexes) and sequestering it away from participation in the final steps of 103 
MAC assembly, thus halting progression of the MAC assembly pathway (Podack et al., 1977, 104 
Milis et al., 1993, Preissner et al., 1989). Vitronectin also has been implicated in direct 105 
interference with C9 polymerization (Milis et al., 1993, Podack et al., 1984). 106 
Resistance of Y. pestis to human serum and complement has been attributed to the 107 
outer membrane protein Ail (Kolodziejek et al., 2007, Bartra et al., 2008). Ail is a 108 
transmembrane protein belonging to the Ail/Lon family, consisting of eight transmembrane β-109 
strands and four extracellular loops. Previous studies have demonstrated that Y. pestis Ail 110 
interacts with C4BP (Ho et al., 2014) and vitronectin (Bartra et al., 2015). Other members of the 111 
Ail/Lon family: Y. enterocolitica Ail, Y. pseudotuberculosis Ail, and Salmonella enterica Rck 112 
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confer varying degrees of serum resistance to their host strains (Heffernan et al., 1992, Bliska & 113 
Falkow, 1992, Yang et al., 1996). Each has the ability to recruit functional C4BP and factor H to 114 
the surface of the bacteria, providing potential mechanisms of serum resistance (Biedzka-Sarek 115 
et al., 2008a, Biedzka-Sarek et al., 2008b, Ho et al., 2012b, Ho et al., 2011, Ho et al., 2010, Ho et 116 
al., 2012a). Specific amino acids in the extracellular loops of Y. enterocolitica Ail and S. enterica 117 
Rck are required for serum resistance in these bacteria (Miller et al., 2001, Cirillo et al., 1996).  118 
In addition to serum resistance, previous studies have demonstrated the importance of 119 
Y. pestis Ail in host cell binding, extracellular matrix (ECM) binding, and Yop (cytotoxin) delivery, 120 
(Felek et al., 2010, Tsang et al., 2010, Yamashita et al., 2011, Felek & Krukonis, 2009). Tsang et 121 
al. recently described the contribution of surface exposed hydrophobic residues, F80, S128, and 122 
F130 to these functions (Tsang et al., 2017). Cumulative mutation of these residues (Ail-123 
F80A/F130A and Ail-F80A/S128A/F130A) resulted in substantial defects in cell adhesion, ECM 124 
binding, Yop delivery, and auto-aggregation, while Ail-F94 played a particularly critical role in 125 
fibronectin binding (Tsang et al., 2017).  Despite these defects in binding to multiple substrates, 126 
Ail-F80A/F130A and Ail-F80A/S128A/F130A maintained strong serum resistance (10,000-fold 127 
higher than a Δail strain). Since Ail-S128A contributes minimally to Ail-mediated serum 128 
resistance (Tsang et al., 2017), studies presented here utilize Ail-F80A/F130A to assess 129 
mechanisms of serum resistance. 130 
In this study, we found Ail-F80A/F130A also failed to interact with vitronectin, factor H, 131 
and C4BP, despite providing 10,000-fold greater serum resistance activity than a Δail mutant. 132 
Cumulative substitutions in Ail residues, along with F80A/F130A, identified an Ail molecule 133 
completely defective in conferring serum resistance. Thus, Ail can provide serum resistance via 134 
multiple mechanisms and recruitment of vitronectin, factor H, and C4BP is largely dispensable 135 
for Ail-mediated serum resistance.  136 
RESULTS 137 
The alternative pathway of complement is responsible for killing Y. pestis Δail. Y. pestis is 138 
resistant to high levels of human serum and this resistance is dependent completely on Ail 139 
(Kolodziejek et al., 2007, Bartra et al., 2008). To determine the pathway of complement, CP, LP, 140 
or AP, responsible for killing a Δail mutant, we assessed serum resistance under conditions that 141 
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inhibit specific pathways of complement killing. Y. pestis strains were incubated with normal 142 
human serum (NHS) or NHS treated with 5mM EGTA and 10mM MgCl2
 157 
 (NHS-AP) which 143 
eliminates any contribution of the classical (CP) or lectin pathways (LP) of complement killing 144 
(Fig. 1)(Des Prez et al., 1975). While the Δail strain was ~100,000-fold defective for survival in 145 
NHS, chromosomally expressed wild-type Ail, Ail-F80A, or Ail-F130A conferred 100% serum 146 
resistance similar to previous findings (Tsang et al., 2017). Furthermore, Ail-F80A/F130A had 147 
only a modest (6-fold) survival defect in NHS compared to the wild-type Ail as previously 148 
reported (Tsang et al., 2017).  Serum inactivated for CP and LP (NHS-AP) had no statistically 149 
significant difference in killing of Δail or Ail-F80A/F130A compared to NHS, as determined by 150 
two-way ANOVA analysis (Fig. 1). Thus, killing of Δail and Ail-F80A/F130A is mediated by the 151 
alternative pathway of complement. To further demonstrate that the AP system of 152 
complement is the main mediator of Δail killing, C4-depleted serum, which lacks activity of only 153 
the CP and LP, retained >1,000-fold greater bactericidal activity against Y. pestis Δail than cells 154 
expressing wild-type Ail (Fig. S1A), while addition of 5mM EDTA, which prevents the function of 155 
all three complement pathways, prevented killing of the Δail mutant (Fig. S1B). 156 
Ail-dependent recruitment of the complement regulators, factor H and Vitronectin, requires 158 
residues F80 and F130. Y. pestis Ail has previously been shown to recruit the complement 159 
regulatory factors C4BP and vitronectin (Ho et al., 2014, Bartra et al., 2015) and the closely 160 
related Ail protein from Y. pseudotuberculosis recruits C4BP and factor H (Ho et al., 2012a, Ho 161 
et al., 2012b). Since a Y. pestis strain expressing Ail-F80A/F130A exhibited only six-fold less 162 
serum resistance than a strain expressing wild-type Ail, while remaining ~10,000-fold more 163 
serum resistant than Δail (Fig.1, (Tsang et al., 2017)), we determined whether residues F80 and 164 
F130 contribute to Y. pestis Ail-mediated recruitment of complement regulatory proteins as a 165 
mechanism of serum resistance. Co-sedimentation assays were performed with strains 166 
expressing Ail-F80A, Ail-F130A, and Ail-F80A/F130A to assess vitronectin and factor H binding. 167 
Y. pestis at a final OD620 = 50 (~1.5 x 10
10
 CFU/mL) were incubated with 50% NHS and evaluated 168 
for serum protein binding by co-sedimentation of complement proteins and Western blotting. 169 
Vitronectin co-sedimented with strains expressing wild-type Ail, but was only minimally bound 170 
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in bacterial pellets of strains expressing Ail containing mutations to either F80 or F130 (Fig. 2A). 171 
Statistical analysis, adjusting for multiple comparisons using Tukey’s post hoc test, revealed that 172 
Ail-F80A/F130A showed a strong trend towards decreased vitronectin recruitment without 173 
reaching statistical significance (p=0.0576) compared to wild-type. However, in a pairwise 174 
comparison, Ail-F80A/F130A recruited significantly less vitronectin (p<0.05). Given that much 175 
more vitronectin is recruited by Ail in the absence of the outer membrane protease 176 
plasminogen activator (Pla) (Fig. 2A, lane 9), we hypothesize vitronectin is cleaved by Pla, as 177 
previously demonstrated (Bartra et al., 2015). Furthermore, co-sedimentation with the Δpla 178 
mutant reveals that Ail can bind full length and degraded forms of vitronectin (Fig. 2A, lane 9).  179 
Y. pestis also exhibited Ail-dependent recruitment of factor H, which was also cleaved by 180 
Pla into discrete bands (Fig. 2B). Previous studies have also indicated Pla is capable of cleaving 181 
factor H (Riva et al., 2015). A strain lacking Ail recruited 33% of the factor H recruited by a strain 182 
expressing wild-type Ail.  Ail-F80A and Ail-F130A had significantly decreased levels of factor H 183 
recruitment, while a double mutant Ail-F80A/F130A had levels of recruitment (37%) 184 
comparable to the Δail strain.  185 
C4BP had a co-sedimentation profile similar to that of factor H, having a partial defect in 186 
C4BP recruitment with the Ail-F80A mutant and a complete loss of binding with the 187 
Ail-F80A/F130A mutant (Fig. 2C). Furthermore, C4BP was cleaved by Pla (Fig. 2C). While C4BP 188 
contributes primarily to regulation of CP and LP, which are not involved in killing Δail (Fig. 1), it 189 
also can play a minor role in control of C3 activation in the AP of complement, albeit to a much 190 
lesser extent than factor H (Seya et al., 1995, Blom et al., 2003). 191 
These data demonstrate that strains expressing Ail-F80A/F130A lose the ability to 192 
recruit three complement regulatory factors vitronectin, factor H, and C4BP, comparable to 193 
recruitment by Δail. Despite the inability to recruit those factors, the Ail-F80A/F130A mutant 194 
maintains ~10,000 fold serum resistance (Fig.1). Therefore, an alternate Ail-dependent 195 
mechanism of complement evasion exists. 196 
 197 
Additional amino acid substitutions to Ail-F80A/F130A result in serum sensitivity comparable 198 
to Δail. Several Ail/Lon family members in other bacterial pathogens confer serum resistance 199 
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including Y. enterocolitica Ail, Y. pseudotuberculosis Ail, and S. enterica Rck (Heffernan et al., 200 
1992, Bliska & Falkow, 1992, Yang et al., 1996). Extensive studies on the involvement of Y. 201 
enterocolitica Ail residues in adhesion and serum resistance revealed the contribution of D90 202 
and V91 (numbered according to the unprocessed form) to serum resistance (Miller et al., 203 
2001). Expressing double mutants, Ailent-D90A/V91R and Ailent
Therefore, we mutated the homologous residues (D93/F94) in combination in Y. pestis 206 
Ail (Fig. 3A). Strains expressing Ail-D93A/F94R or Ail-D93G/F94G from the plasmid pMMB207 207 
had no significant difference in serum resistance compared to wild-type Ail (Fig. 3B). Ail-208 
D93A/F94R resulted in slight decreases in recruitment of vitronectin to 58% of wild-type Ail (Fig. 209 
4A), compared to 14% recruitment exhibited by Ail-F80A/F130A and 13% by Δail. Similarly, Ail-210 
D93A/F94R was defective for factor H recruitment (48% relative to wild type Ail) while Ail-211 
D93G/F94G displayed no significant decrease in recruitment of factor H (Fig. 4B). Ail-212 
F80A/F130A recruited only 7% of factor H relative to wild-type Ail (Fig. 4B). When combined 213 
with the F80A/F130A mutation, the D93/F94 mutations reduced Ail-mediated serum resistance 214 
to levels statistically indistinguishable from an ail mutant (Fig. 3B). Additionally, recruitment of 215 
vitronectin and factor H was eliminated in strains expressing Ail-D93/F94 mutations in 216 
combination with the F80A/F130A mutations (Fig. 4A), as expected due to dependence on F80 217 
and F130 for binding (Fig. 2AB).  218 
-D90G/V91G both resulted in 204 
serum sensitivity in Y. enterocolitica (Miller et al., 2001).  205 
 Cell adhesion/invasion and serum resistance activities are conferred upon S. enterica by 219 
the protein Rck (Cirillo et al., 1996, Heffernan et al., 1992). Amino acids D43 and G118 of Rck, 220 
when mutated to D43K and G118D respectively, caused decreases in serum resistance. The 221 
greatest drop in resistance was revealed when both residues were mutated in combination 222 
(Cirillo et al., 1996).  To address the contribution of homologous residues in Y. pestis Ail, we 223 
generated the variants E43K and G122D (Fig. 3A). Individually, these substitutions in Ail led to 2 224 
to 3-fold decreases in serum resistance compared to wild-type Ail (Fig. 3B). A strain expressing 225 
the double mutant, Ail-E43K/G122D, had a much larger defect in serum resistance (1000-fold 226 
decrease in survival), and when combined with F80A/F130A, the quadruple mutant, Ail-227 
F80A/F130A/E43K/G122D, had an additional 10-fold decrease in serum resistance, comparable 228 
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to Δail containing empty pMMB207, although after adjusting the statistical analysis for multiple 229 
comparisons, the difference in serum resistance between Ail-E43K/G122D and Ail-230 
F80A/F130A/E43K/G122D was not significant (Fig. 3B).  231 
Regarding recruitment of complement regulatory proteins, Ail-E43K/G122D maintains 232 
similar levels of vitronectin and factor H recruitment as Ail-D93A/F94R (Fig. 4), yet Ail-233 
E43K/G122D loses 1,000-fold serum resistance activity, while the Ail-D93A/F94R mutant 234 
maintains ~100% serum resistance (Fig. 3B). Together, these data show that residues E43 and 235 
G122 play a minor role in co-sedimentation of complement regulators, but an important role in 236 
Y. pestis serum resistance by an additional mechanism. 237 
It should be noted that all Ail mutants reported have been shown to be stably expressed 238 
in the outer membrane of Y. pestis (Fig. S2). 239 
 240 
Co-sedimentation of complement components at lower bacterial concentration affects Ail-241 
dependent recruitment of Vn and Factor H. Our initial serum co-sedimentation assays were 242 
performed at a bacterial concentration based on assays in previous studies (Biedzka-Sarek et 243 
al., 2008a, Bartra et al., 2015, Kirjavainen et al., 2008, Ho et al., 2012b). This high bacterial 244 
concentration (OD620 = 50, 1.5 x 10
10
 CFU/mL), while useful to assess binding of serum 245 
components to Y. pestis, is closer to levels seen in late stage plague infection (Sebbane et al., 246 
2005, Lorange et al., 2005). Given that in some cases recruitment of complement regulatory 247 
proteins did not reflect serum bactericidal activity (e.g. Ail-E43K/G122D), we assessed 248 
recruitment of complement regulatory proteins in Y. pestis expressing wild-type Ail, Ail-249 
F80A/F130A, Ail-E43K/G122D, Ail-F80A/F130A/E43K/G122D, or pMMB207 (empty vector) at a 250 
bacterial concentration more closely reflecting early-stage, septicemic plague infection (OD620 = 251 
0.25, 7.5 x 10
7 
At the lower bacterial concentration, the level of Ail-dependent recruitment of 254 
vitronectin dropped to 2-fold above the background of the Δail mutant (Fig. 5A). This modest 255 
level of vitronectin recruitment was lost with the Ail-F80A/F130A mutant. Additionally, Ail-256 
E43K/G122D and Ail-F80A/F130A/E43K/G122D failed to recruit Vn at the reduced bacterial 257 
CFU/mL) (Sebbane et al., 2005). This is also a bacterial density closer to how 252 
serum resistance assays are routinely performed.  253 Au
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density (Fig. 5A). Similarly, Ail-dependent binding of factor H was completely lost at the lower 258 
bacterial concentration (Fig. 5B). Cleavage of recruited serum factors by Pla was determined to 259 
be a result of the high bacterial density used in the previous experiments, as at lower bacterial 260 
density the recruited proteins vitronectin and factor H were mostly full length with little to no 261 
degradation (Fig. 5). This suggested Pla cleavage of Vn and factor H may be due to interbacterial 262 
cleavage, not cleavage by Pla on the same bacterial surface. Additionally, the higher 263 
concentration of Pla at OD620
 267 
=50 may allow for cleavage of poorly-recognized substrates. These 264 
trends in recruitment further indicate that another mechanism of serum resistance is utilized by 265 
Y. pestis under bacterial concentrations achieved during plague infections. 266 
MAC assembly occurs to a higher extent in serum sensitive mutants. Δail exhibits minimal 268 
recruitment of complement regulatory factors and we observed similarly low levels of 269 
recruitment in Ail-F80A/F130A and Ail-F80A/F130A/E43K/G122D regardless of bacterial 270 
concentrations used during co-sedimentation. However, Ail-F80A/F130A confers 10,000-fold 271 
greater serum resistance than Ail-F80A/F130A/E43K/G122D. Thus, Ail-F80A/F130A must 272 
maintain a mechanism of serum resistance disrupted by the E43K/G122D mutations.  In fact, 273 
even the Ail- E43K/G122D double mutant (with F80 and F130 intact) has a 500-fold defect in 274 
serum resistance relative to Ail-F80A/F130A. In S. enterica, D43K and G118D mutations in Rck 275 
disrupt the ability of Rck to prevent C9 polymerization, the last step in MAC formation (Cirillo et 276 
al., 1996, Heffernan et al., 1992). Thus, we assessed levels of C9 polymerization on the surface 277 
of Y. pestis in the presence of various Ail derivatives. Strains were mixed at low concentration 278 
(OD620 = 0.25, 7.5 x 10
7 
CFU/mL) with NHS and subjected to non-reducing SDS-PAGE followed by 279 
Western blotting, as polymerized-C9 is SDS-resistant (Podack & Tschopp, 1982). An anti-C9 280 
antibody was used to assess levels of polymerized C9. Zymosan-activated NHS was used as a 281 
positive control for C9 polymerization and untreated NHS was shown as a control for 282 
monomeric C9. Serum sensitive Δail with empty vector displayed the highest level of high 283 
molecular weight polymerized C9 as expected (Fig. 6, lane 2). Serum resistant wild-type Y. pestis 284 
and Ail-F80A/F130A exhibited the lowest levels of polymerized C9 (Fig. 6, lanes 3 and 4), 39% 285 
and 42% relative to Δail, respectively. The levels of C9 polymerization were increased in strains 286 
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expressing Ail-E43K/G122D and Ail-F80A/F130A/E43K/G122D, however the levels in 287 
Ail-F80A/F130A/E43K/G122D remained significantly lower than Δail. This finding suggests that 288 
there may be a threshold level of polymerized C9 that correlates with serum resistance. The 289 
serum sensitive strain, Ail-F80A/F130A/E43K/G122D, has less polymerized C9 incorporated than 290 
Δail, but allows enough MAC assembly to render it serum sensitive. 291 
 Additional experiments were attempted to confirm C9 polymerization defects using the 292 
anti-C9 neo-antigen antibody aE11 (Life Technologies), that only recognizes fully polymerized 293 
poly C9 (Kolb & Muller-Eberhard, 1975). Unfortunately, to obtain complete MAC assembly (and 294 
C9 polymerization) as reflected by bacterial killing, such a low bacterial density was required in 295 
the presence of 50-80% human serum that we could not reliably precipitate so few bacteria to 296 
enable processing of the neo-antigen Ab binding studies with any consistency by ELISA assay. 297 
 298 
DISCUSSION 299 
 Ail is a multi-functional outer membrane protein involved in cell adhesion, binding to 300 
ECM components, Yop delivery, and serum resistance, thus delivering important functions 301 
during various stages in Y. pestis infection (Felek & Krukonis, 2009, Felek et al., 2010, Tsang et 302 
al., 2010, Yamashita et al., 2011, Bartra et al., 2008, Kolodziejek et al., 2007, Kolodziejek et al., 303 
2010). In late-stage plague infection, Y. pestis survive in blood and grow to a high-level 304 
septicemia approaching 10
10
 Two residues of Ail, F80 and F130, mediate cell-binding, binding to extracellular matrix 312 
proteins, and facilitate Yop delivery (Tsang et al., 2017). Mutation of both residues to alanine 313 
leads to only a modest decrease (three to six-fold) in serum resistance compared to a wild-type 314 
Y. pestis strain, while remaining 10,000-fold more resistant to serum than an ail deletion 315 
CFU/mL (Sebbane et al., 2005) despite the bactericidal effects of 305 
complement in serum. High level septicemia allows for transmission to a new flea vector during 306 
a blood meal (Lorange et al., 2005). Ail is necessary and sufficient to confer resistance to serum 307 
to Y. pestis, providing 100,000-fold greater evasion of complement-mediated killing than a 308 
strain lacking ail (Tsang et al., 2017, Bartra et al., 2015, Kolodziejek et al., 2007). In this study, 309 
we show that a ∆ail mutant is efficiently killed in 80% NHS during in vitro serum resistance 310 
assays and this killing is attributed to the alternative pathway of complement (Fig. 1).  311 Au
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mutant (Figs. 1, 3B (Tsang et al., 2017)). However, Ail-F80A/F130A is unable to recruit 316 
alternative pathway complement regulatory factors, such as vitronectin (Vn) and factor H, at 317 
both high cell density (Fig. 2A,B) and lower cell concentration (Fig. 5A,B) the latter being more 318 
physiologically relevant to bacterial levels in blood during early-stage septicemic plague (Perry 319 
& Fetherston, 1997, Lorange et al., 2005, Sebbane et al., 2005). Recruitment of complement 320 
regulatory proteins is a complement evasion tactic employed by a multitude of pathogens 321 
(Hovingh et al., 2016). However, recruitment of complement regulators by Ail-F80A/F130A is 322 
indistinguishable from recruitment by a ∆ail mutant. Thus, Ail-F80A/F130A must be providing 323 
serum resistance via a different mechanism.  324 
 Site-directed mutagenesis targeting amino acids in Y. pestis Ail, based on previous 325 
studies with Ail homologs in Y. enterocolitica (Ail) and S. enterica (Rck), was performed to 326 
determine essential residues in Y. pestis Ail that contribute to serum resistance. One mutant, 327 
Ail-E43K/G122D, based on studies on S. enterica Rck (Cirillo et al., 1996), had a large defect in 328 
serum resistance, even when F80 and F130 were intact. Alternatively, mutations of D93/F94 329 
(based on studies with Y. enterocolitica Ail (Miller et al., 2001)) had no effect on Y. pestis serum 330 
resistance and required being combined with the F80A/F130A mutations to result in a loss of 331 
serum resistance. Based on the dramatic loss in serum resistance activity of Ail-332 
F80A/F130A/D93A/F94R and Ail-F80A/F130A/D93G/F94G compared to Ail-F80A/F130A (Fig. 333 
3B), residues D93 and F94 clearly contribute to serum resistance activity. However, defects 334 
associated with mutations in D93 and F94 are masked by wild-type F80 and F130 residues. In 335 
contrast to the Ail-F80A/F130A mutant, mutations of E43, G122, D93, and F94 had little impact 336 
on recruitment of Vn and factor H, similar to studies done on homologous residues in Y. 337 
enterocolitica Ail (Biedzka-Sarek et al., 2008b).  338 
At bacterial concentrations reflective of late-stage septicemic plague, we saw a 10-fold 339 
increase in Vn recruitment and a 3-fold increase in factor H recruitment in wild-type Y. pestis 340 
relative to a Δail mutant (Fig. 2AB). At a lower bacterial concentration, we saw only a 2-fold 341 
increase in Vn recruitment relative to the Δail mutant (Fig. 5A) and wild-type Ail mutant actually 342 
showed less membrane-associated factor H than the Δail mutant (Fig. 5B, blots were over-343 
developed to detect weak factor H binding). These data indicate a potential disparity in 344 
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complement regulator recruitment depending on the bacterial concentration at various stages 345 
of plague infection. These findings suggest the major alternative pathway complement 346 
regulators Vn and factor H may not play a role in serum resistance during early stages of 347 
septicemic plague and instead Y. pestis relies on our newly described alternative mechanism of 348 
Ail-mediated serum resistance for survival in blood during this critical stage of infection. 349 
Studies showing Ail-dependent recruitment of C4BP and factor H by Y. 350 
pseudotuberculosis (Ho et al., 2012a, Ho et al., 2012b) and Y. enterocolitica (Kirjavainen et al., 351 
2008, Biedzka-Sarek et al., 2008a), as well as C4BP in Y. pestis (Ho et al., 2014), revealed that 352 
regulators were bound and facilitated cofactor-dependent inactivation of C4b and C3b, 353 
respectively. Based on these regulatory protein binding and functionality studies in other 354 
Yersinia spp., it is plausible that Y. pestis Ail also recruits fully functional factor H (Fig. 2B) that 355 
retains the ability to inactivate C3b.  However, it should be noted that at high bacterial 356 
concentrations, Pla, which is unique to Y. pestis, degrades factor H, C4BP and  Vn (Fig. 2, (Bartra 357 
et al., 2015)). The fact that the ∆ail strain and strains expressing Ail-F80A/F130A and 358 
Ail-F80A/F130A/E43K/G122D recruited similar levels of vitronectin at lower bacterial 359 
concentration (Fig. 5A), but only Ail-F80A/F130A conferred serum resistance (Fig. 3B) indicates 360 
serum resistance of Ail-F80A/F130A is conferred by an alternate Ail-dependent mechanism.  361 
Finally, we analyzed the extent of MAC maturation in Y. pestis by measuring levels of C9 362 
polymerization by Western blotting. Y. pestis Δail (containing the empty vector pMMB207), 363 
which is highly serum sensitive, had the greatest degree of polymerized C9, as expected. When 364 
wild-type Ail was expressed, the amount of C9 in the polymerized form was drastically 365 
decreased (39% of Δail, Fig. 6). Y. pestis expressing Ail-F80A/F130A also inhibited the 366 
maturation of the MAC (Fig. 6), reflecting its serum resistance activity (Figs. 1 and 3B). Rck of S. 367 
enterica confers serum resistance via inhibition of C9 polymerization (Cirillo et al., 1996, 368 
Heffernan et al., 1992) and mutation of D43 and G118 in Rck eliminates serum resistance 369 
activity (Cirillo et al., 1996, Heffernan et al., 1992). Y. pestis expressing the homologous mutant 370 
Ail-E43K/G122D had reduced serum resistance (Fig. 3B), approaching the levels of a ∆ail 371 
mutant. These mutations have little effect on the recruitment of vitronectin and factor H (Figs. 372 
4, 5), but Y. pestis expressing Ail-E43K/G122D display significantly more polymerized C9 373 
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compared to wild-type Ail and Ail-F80A/F130A (Fig. 6). Therefore, it is plausible that E43 and 374 
G122 of Y. pestis Ail may mediate direct inhibition of C9 polymerization similar to the proposed 375 
mechanism of serum resistance conferred by Rck. 376 
It should be noted that due to the bacterial densities used for these studies, C9 was not 377 
fully assembled to the MAC and what is observed is partially polymerized C9 (Fig. 6; compare 378 
sizes of poly-C9 with Y. pestis to the fully assembled MAC in the zymosan-activated sample). 379 
Attempts to reduce the bacterial concentration to allow for more complete MAC assembly on 380 
each Y. pestis membrane surface were hampered by the inability to reproducibly precipitate so 381 
few bacteria. This limitation also prevented us from assessing C9 polymerization by a secondary 382 
assay of MAC assemble, neo-antigen exposure, which is dependent on complete MAC assembly 383 
(Kolb & Muller-Eberhard, 1975). 384 
Various mechanisms beyond recruitment of host complement regulatory proteins and 385 
inhibition of C9 polymerization, are employed by pathogens to evade complement. One such 386 
mechanism is sequestration of C7 by Borrelia burgdorferi (Hallstrom et al., 2013). CspA of B. 387 
burgdorferi, similar to Y. pestis Ail, is involved in many facets of complement evasion. CspA 388 
binds factor H, while also binding C7 and C9, primarily interfering with maturation of the MAC 389 
at the C7 step (Hallstrom et al., 2013). We found Y. pestis Ail also mediated binding to C7 at 390 
both high and low bacterial concentration, (Fig. S3AB). Ail may play a role in binding C7 to 391 
inhibit MAC maturation at the step of C7, however this recruitment C7 may also be attributed 392 
to vitronectin-associated C5b-C7, C5b-C8 and C5b-C9 complexes (Podack et al., 1977, Preissner 393 
et al., 1989). Ail can also mediate binding to C6 at low cell density, whereas, at high bacterial 394 
concentration C6 recruitment is only seen in the absence of Pla (Fig. S3AB). Expression of Ail-395 
F80A/F130A leads to a decrease in membrane-associated C6 and C7 compared to wild-type Ail, 396 
which is consistent with the loss of binding to vitronectin. Binding to C8 and C9 remains 397 
consistent regardless of the bacterial cell concentration or the presence of Ail. We interpret this 398 
to reflect the fact that C8 and C9 are inserted into the membrane of serum-sensitive mutants 399 
like Ail-E43K/G122D or Ail-F80A/F130A/E43K/G122D, while for serum-resistant strains like 400 
those expressing wild-type Ail or Ail-F80A/F130A, C8 and C9 would be recruited as part of the 401 
Vn/C5b-C8 and C5b-C9 complexes (Preissner et al., 1989). Our findings indicate that what 402 
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distinguishes serum-sensitive strains of Y. pestis (Δail, Ail-E43K/G122D, Ail-403 
F80A/F130A/E43K/G122D) from serum-resistant strains (expressing wild-type Ail, Ail-404 
F80A/F130A) is the higher level of polymerized C9 in the serum-sensitive strains (Fig. 6). 405 
Additionally, Ail-F80A/F130A has less binding to vitronectin as well as less membrane-406 
associated C6 and C7 while remaining serum resistant, suggesting other amino acids (E43 and 407 
G122) may be involved with interrupting progression to the MAC at the level of C8 and C9 408 
interaction/polymerization. 409 
We noted Pla was able to cleave Vn, factor H, and C4BP (Fig. 2) as has been shown 410 
previously with several substrates (Riva et al., 2015, Bartra et al., 2015, Caulfield et al., 2014, 411 
Caulfield & Lathem, 2012, Sodeinde et al., 1992, Sodeinde et al., 1988). However, for Vn and 412 
factor H, Pla-mediated cleavage required a high cell density (Figs. 2, 5), suggesting that cleavage 413 
of complement proteins occurs via Pla proteases on neighboring bacterial cells (interbacterial 414 
cleavage). Pla also plays a role in cleavage of C3, however Pla mutants remain completely 415 
resistant to high levels of human serum (Sodeinde et al., 1992), indicating the unlikelihood that 416 
Pla plays a role in in vitro complement-mediated lysis. The fact that Pla cleaves multiple 417 
complement regulatory proteins calls into question the role of these proteins in serum 418 
resistance of Y. pestis. Further studies are needed to determine whether Pla-degraded forms of 419 
these proteins are still able to interrupt serum-dependent killing. 420 
Animal studies with Δail mutants suggested that Ail interferes with the production of 421 
C3a and C5a (potentially via factor H recruitment) due to the observation of a strong influx of 422 
polymorphonuclear leukocytes (PMN) to the site of infection in a ∆ail mutant (Hinnebusch et 423 
al., 2011). Our assays detect factor H binding at high concentrations of Y. pestis, which may 424 
indicate that Ail-dependent recruitment of factor H in buboes may prevent production of the 425 
alarmones, C3a and C5a, thus preventing PMN infiltration. Alternatively, it is possible the lack of 426 
PMN recruitment seen during bubonic plague models of infection are due to a reduced 427 
efficiency of Yop delivery via T3SS in a ∆ail mutant (Marketon et al., 2005, Merritt et al., 2014). 428 
Nonetheless, our studies show Y. pestis can survive complement-mediated lysis in human 429 
serum, even without the ability to recruit factor H or vitronectin (as demonstrated by Ail-430 
F80A/F130A).  431 
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 Defining the amino acids of Ail involved in preventing complement-mediated lysis 432 
further elucidates the role of Ail during host infection. We have found residues in Ail (F80 and 433 
F130) that not only mediate cell binding, binding to ECM, and Yop delivery (Tsang et al., 2017), 434 
but also facilitate the binding/recruitment of complement regulatory proteins (Vn, factor H, and 435 
C4BP) to the bacterial surface. We found that Ail residues (E43 and G122), when mutated in 436 
combination decrease serum resistance, while regulatory protein binding remains relatively 437 
unchanged, implicating an alternative mechanism of serum resistance in addition to/instead of 438 
complement regulatory protein recruitment. This alternative mechanism may be direct 439 
interference with C9 polymerization. The role of serum resistance during plague infection is not 440 
well defined, however, Y. pestis must have the ability to survive in blood to reach the high levels 441 
of bacteremia needed to be transmitted to a new flea host during feeding (Lorange et al., 442 
2005). Experiments comparing the role of Ail during mouse infections (mouse serum is not 443 
bactericidal for a ∆ail mutant, (Bartra et al., 2008)) compared to rat studies (rat serum is 444 
bactericidal for a ∆ail mutant, (Bartra et al., 2008)) suggest an important role for Ail-mediated 445 
serum resistance during human plague infections (reflective of rat infections, (Hinnebusch et 446 
al., 2011, Kolodziejek et al., 2010)), but this hypothesis has yet to be tested. Future studies will 447 
assess the contribution of specific Ail residues defined in this study to serum resistance in vivo, 448 
and will clarify the role of Ail during the course of Y. pestis infection.  449 
 450 
 451 
 452 
EXPERIMENTAL PROCEDURES 453 
Bacterial strains and growth conditions. Y. pestis KIM5 strains were cultured overnight in heart 454 
infusion broth (HIB) or on heart infusion agar (HIA) for 48 hours at 28°C. Escherichia coli strains 455 
were grown overnight in Luria-Bertani (LB) broth or LB agar at 37°C. Antibiotics were used at 456 
the following concentrations: chloramphenicol (25µg/mL), ampicillin (100µg/mL), and 457 
kanamycin (30µg/mL). Isopropyl-β-D-thiogalactopyranoside (IPTG) was used at concentrations 458 
of 100µM or 500µM depending on assay. Characteristics of strains and plasmids used in this 459 
study are listed in Table S1. 460 
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 461 
Strain and plasmid construction. Strains containing mutated ail alleles recombined into the ail 462 
locus were created in a previous study (Tsang et al., 2017). These strains were subjected to λ-463 
RED recombination to knockout pla as in (Felek et al., 2010). Deletions were confirmed by PCR 464 
and plasminogen activator assays.  465 
 Site-directed mutagenesis of Ail was conducted using whole-plasmid replication using 466 
primers designed according to the protocol in (Liu & Naismith, 2008). Briefly, primers (listed in 467 
Table S2) were designed to incorporate desired mutation/s to ail using pSK-Bluescript-ail 468 
plasmid as a template (Tsang et al., 2017). PCR reactions were conducted using Phusion High-469 
Fidelity DNA Polymerase (Thermo) and the following cycle settings: 94°C for 3 minutes, then 25 470 
cycles of 94°C for 1 minute, 52°C for 1 minute, 72°C for 6 minutes, followed by a final extension 471 
at 72°C for 60 minutes. PCR reactions were then subjected to DpnI restriction digestion to 472 
degrade template DNA followed by transformation into E. coli DH5α + pREP4. Potential mutants 473 
were sequenced to confirm mutation. Sequenced clones were digested with BamHI and PstI to 474 
isolate the entire ail locus and ribosomal binding site and were ligated into pMMB207. 475 
 476 
Serum resistance assay. Strains were grown overnight in HIB at 28°C, subcultured 1:50 into 477 
fresh HIB and incubated while shaking for 3 hours at 28°C. Subcultures of strains containing 478 
pMMB207 derivatives were subcultured with the addition of 500µM. Cultures were 479 
resuspended in PBS to OD620 = 0.5 and further diluted 1:10 in PBS. 50µL cells was mixed with 480 
200µL Normal Human Serum (NHS) (Sigma) or Heat-Inactivated Serum (HIS). HIS was prepared 481 
by incubating NHS at 56°C for 30 minutes. For alternative pathway only serum (NHS-AP), 5mM 482 
EGTA and 10mM MgCl2 
 487 
was added to NHS. Bacterial counts were enumerated by colony 483 
counting. Percent serum resistance was calculated by the number of surviving colonies in NHS 484 
or NHS-AP/HIS x 100. Strains were tested a minimum of 3 times in separate experiments. 485 
Significance was determined using the Student’s t-test.  486 
Serum co-sedimentation assay. Strains were grown overnight in HIB +/- 100µM IPTG 488 
depending on experiment. Cultures were centrifuged, washed once with 1mL PBS, and 489 
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resuspended to OD620 = 100 or 0.5 in PBS. For cultures resuspended to OD620 = 100, 50µL 490 
culture (~1.5 x 10
9 
CFU) was mixed with 50µL NHS (Final OD620 = 50, ~1.5 x 10
10
 CFU/mL). For 491 
cultures resuspended to OD620 = 0.5, 250µL of culture (~7.5 x 10
6
 CFU) was mixed with 250µL 492 
NHS (Final OD620 = 0.25, ~7.5 x 10
7
 CFU/mL). Mixtures were shaken vigorously (300rpm) at 37°C 493 
for 30 minutes. Samples were then incubated for 5 minutes on ice and centrifuged at 4°C. 494 
Pellets were washed 3 times with cold PBS. Co-sedimentation mixtures at OD620 = 50 were 495 
resuspended in 200µL 1X reducing protein buffer (50mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 496 
0.1% Bromophenol blue, 100mM dithiothreitol). Cultures at OD620 
 500 
= 0.25 were resuspended in 497 
50µL 1X reducing protein buffer. Samples were subjected to analysis by western blotting for 498 
complement factors and Coomassie blue staining for expression of Ail.  499 
Protein expression and western blot analysis. Cultures of Y. pestis or co-sedimentation 501 
reactions were resuspended in Laemmli sample buffer (+/- DTT) normalizing for OD620. Samples 502 
were boiled for 5 minutes and subjected to 15% SDS-polyacrylamide gel electrophoresis (PAGE) 503 
for determination of Ail expression followed by Coomassie blue staining, where Ail is identified 504 
as a band at approximately 15kDa (Felek & Krukonis, 2009). Co-sedimentation samples were 505 
run on 7.5% SDS-PAGE gel (poly-C9 detection run on 4%-15% gradient gel (Bio-Rad)), followed 506 
by blotting on polyvinylidene fluoride (PVDF) membrane for visualization of complement 507 
factors by western blotting. Primary antibodies were added at the following dilutions: 508 
polyclonal anti-human vitronectin (1:20,000) (Complement Technology-A260), polyclonal anti-509 
human factor H (1:2,000) (Complement Technology-A237), polyclonal anti-human C4BPA 510 
(1:10,000) (Thermo PA5-42001), polyclonal anti-human C9 (1:5,000) (Complement Technology-511 
A226), monoclonal anti-Escherichia coli RNA polymerase alpha (1:1000) (Neoclone). Anti-goat 512 
IgG (1:30,000) (Thermo) and anti-rabbit IgG (1:5,000) (Invitrogen) conjugated to alkaline 513 
phosphatase were used followed by visualization of bands using immuno-BCIP (5-bromo-4-514 
chloro-3-indolylphosphate)-nitroblue  tetrazolium  liquid  substrate (Sigma). Quantification of 515 
band intensity was performed using ImageJ software (NIH). Complement factor recruitment 516 
was calculated/displayed as a % of the factor recruited by Y. pestis expressing wild-type Ail. 517 
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Data analysis and statistics. Statistical analyses were conducted using GraphPad Prism 518 
Software (GraphPad, La Jolla, CA, USA). Two-way analysis of variance (ANOVA) with Tukey’s 519 
post hoc test was performed to analyze the levels of serum resistance in strains containing 520 
various ail mutations in both NHS and NHS-AP (Figure 1).  One-way ANOVA with Tukey post hoc 521 
test was used for comparisons of resistance to NHS between Y. pestis strains expressing Ail 522 
variants from a plasmid (Figure 3B). One-way ANOVA with Tukey post hoc test was performed 523 
on all densitometric analyses of western blots for comparisons of recruited complement 524 
proteins between Y. pestis strains (Figures 2, 4, 5, 6). Data are presented as mean ± standard 525 
deviation. * were used to denote significance (p<0.05) as determined by post hoc test. 526 
 527 
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GRAPHICAL ABSTRACT 539 
Attached 540 
 541 
ABBREVIATED SUMMARY 542 
To survive in humans, Yersinia pestis must prevent killing by the human complement system. 543 
We show hydrophobic residues F80 and F130 in the extracellular loops of Ail are required to 544 
recruit the complement regulatory proteins Factor H and vitronectin, but their recruitment is 545 
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largely dispensable for survival in serum. Thus, we propose an additional mechanism of Ail-546 
mediated serum resistance involving interference with C8 or C9 in the final steps of membrane 547 
attack complex assembly. 548 
 549 
FIGURE LEGENDS 550 
Figure 1. Killing of Y. pestis Δail by human serum is mediated by the alternative pathway of 551 
complement. ~7.5 x 10
5
 CFU of mid-log cultures of Y. pestis strains containing wild-type Ail, a 552 
chromosomal deletion of ail (Δail), or chromosomal ail recombinants were treated with 80% 553 
NHS, 80% HIS (Heat-inactivated serum), or 80% NHS-AP (NHS treated with 5mM EGTA and 10mM 554 
MgCl2
 561 
 to inactivate CP/LP) for one hour at 37°C. Surviving bacteria were plated and 555 
enumerated by colony counting. Percent serum resistance was calculated as the number of 556 
surviving colonies in NHS/HIS or NHS-AP/HIS x 100 and is displayed on a logarithmic scale. 557 
Strains were tested a minimum of 3 times for each condition in separate experiments. 558 
Significance was determined using the two-way ANOVA with Tukey’s post hoc test. *, p-value < 559 
0.05 when compared to the parental KIM5 wild-type (WT) strain in the same serum condition. 560 
Figure 2. Co-sedimentation of complement regulatory factors with Y. pestis is mediated by Ail 562 
extracellular loop residues F80 and F130. Overnight cultures of Y. pestis KIM5 strains 563 
containing wild-type Ail, a chromosomal deletion of ail, or specific chromosomal alleles of ail 564 
were mixed with 50% NHS to a final OD620 = 50. Mixtures were shaken vigorously at 37°C for 30 565 
minutes. Cells were centrifuged, washed, and analyzed by Western blot for the presence of 566 
membrane-associated complement regulators: A) vitronectin (Vn) B) factor H C) C4b-binding 567 
protein (C4BP). Levels of expressed Ail were determined by Coomassie staining. ΔailΔpla strains 568 
are included to show full-length, un-degraded complement regulatory proteins. The cells alone 569 
lane indicates Y. pestis KIM5 cross-reactive bands recognized in the absence of NHS. Blots are 570 
one representative of at least three independent experiments and are shown with the 571 
Coomassie-stained gel showing Ail expression from the same experiment, as well as the loading 572 
control anti-E. coli RNA polymerase alpha. Molecular weight markers are indicated on the left 573 
of the blot. Quantification of band intensity was performed using at least 3 independent 574 
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experiments with ImageJ software (NIH). Intensity of bands corresponding to complement 575 
regulator recruitment is shown as a percentage of WT recruitment (normalized to 100%) in 576 
each individual blot. Significance was determined using one-way ANOVA with Tukey’s post hoc 577 
test. *, p-value < 0.05 when compared to the wild-type strain of Y. pestis KIM5.  Abbreviations: 578 
Vn=vitronectin, C4BP=C4b-binding protein, D=degraded form of protein (degraded by Pla). 579 
 580 
Figure 3. Multiple Ail substitutions required to reveal a serum sensitivity phenotype 581 
comparable to Δail deletion. A) Amino acid substitutions of Y. pestis Ail residues corresponding 582 
to homologous residues that no longer confer full serum resistance in Yersinia enterocolitica Ail 583 
(Miller et al., 2001) and Salmonella enterica Rck (Cirillo et al., 1996). B) Resistance of Y. pestis 584 
KIM5 ∆ail expressing plasmid-borne Ail or Ail derivatives, to killing by normal human serum 585 
(NHS). ~7.5 x 10
5
 CFU of mid-log culture grown with 500µM IPTG (to induce Ail expression) was 586 
added to 80% heat-inactivated serum (HIS) or 80% NHS for one hour at 37
o
 594 
C. Surviving bacteria 587 
were plated and enumerated by colony counting. Percent serum resistance was calculated by 588 
(number of surviving colonies in NHS or NHS-AP/HIS) x 100 and is displayed on a logarithmic 589 
scale. Strains were tested a minimum of 3 times in separate experiments.  Ail expression and 590 
stability was determined by Coomassie staining shown beneath the graph. Significance was 591 
assessed using the one-way ANOVA with Tukey’s post hoc test. *, p-value < 0.05 when 592 
compared to serum resistance of a strain expressing wild-type Ail.  593 
Figure 4. Co-sedimentation of alternative pathway regulatory factors is mediated by various 595 
extracellular loop residues of Y. pestis. Overnight cultures grown in the presence of 100µM 596 
IPTG (to induce Ail expression) were mixed with 50% NHS to a final OD620 = 50. Mixtures were 597 
shaken vigorously at 37°C for 30 minutes. Mixtures were centrifuged and cell pellets were 598 
washed, then subjected to Western blotting for complement regulatory factors: A) vitronectin 599 
(Vn) and B) factor H. All Western blots are accompanied by Coomassie-stained gel showing Ail 600 
expression in the same samples. Molecular weight markers are indicated on the left. The cells 601 
alone lane represents Y. pestis in the absence of NHS. Quantification of band intensity was 602 
performed using at least 3 independent experiments with ImageJ software (NIH). Intensity of 603 
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bands corresponding to complement regulator recruitment is shown as a percentage of WT 604 
recruitment (normalized to 100%) in each individual blot.  Significance was determined using 605 
one-way ANOVA with Tukey’s post hoc test. *, p-value < 0.05 when compared to a strain 606 
expressing wild-type Ail.    607 
 608 
Figure 5. Loss of Ail-mediated recruitment of complement regulatory factors at lower 609 
bacterial concentration. Overnight cultures grown in the presence of 100µM IPTG (to induce Ail 610 
expression) were mixed with 50% NHS to a final OD620 
 622 
= 0.25. Mixtures were shaken vigorously 611 
at 37°C for 30 minutes. Samples were centrifuged and cell pellets were washed, then subjected 612 
to Western blotting for complement regulatory factors: A) vitronectin (Vn) and B) factor H. 613 
Western blots are accompanied by Coomassie-stained gel showing Ail expression in the same 614 
samples, as well as the loading control anti-E. coli RNA polymerase alpha. Molecular weight 615 
markers are indicated on the left. The cells alone lane represents Y. pestis in the absence of 616 
NHS. Quantification of band intensity was performed using at least 3 independent experiments 617 
with ImageJ software (NIH). Intensity of bands corresponding to complement regulator 618 
recruitment is shown as a percentage of wild-type Ail-mediated recruitment (normalized to 619 
100%) in each individual blot.  Significance was determined using one-way ANOVA with Tukey’s 620 
post hoc test. *, p-value < 0.05 when compared to a strain expressing wild-type Ail.    621 
Figure 6. Membrane-association of polymerized C9 is increased in strains lacking ail or 623 
containing multiple mutations to extracellular loops. Overnight cultures grown in the presence 624 
of 100µM IPTG (to induce Ail expression) were mixed with 50% NHS to a final OD620 = 0.25. 625 
Mixtures were shaken vigorously at 37°C for 30 minutes. Samples were centrifuged, cell pellets 626 
were washed, and subjected to Western blotting under non-reducing conditions using an anti-627 
C9 polyclonal antibody. Western blot is one representative of at least three independent 628 
experiments. Ail expression was determined by Coomassie staining and is shown beneath the 629 
blot. Molecular weight markers are indicated on the left of the blot. Cells alone lane represents 630 
Y. pestis in the absence of NHS. Zymosan activated NHS is a positive control for the formation of 631 
polymerized C9 compared to NHS alone (monomeric C9). Quantification of band intensity from 632 
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at least 3 independent experiments was performed using ImageJ software (NIH). Intensity of 633 
bands corresponding to C9 polymerization is shown as a percentage of the ∆ail mutant (a strain 634 
with no ability to inhibit C9 polymerization), which was normalized to 100%. Significance was 635 
determined using one-way ANOVA with Tukey’s post hoc test. *, p-value < 0.05 when compared 636 
to a strain expressing wild-type Ail. 637 
 638 
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